Bio Path Holdings (BPTH) Stock Price
Bio Path Holdings Price
Revenue at Bio Path Holdings has contracted by 3.9% per year over the past 12 years to 37,000.00 USD. For Bio Path Holdings, the net margin of -18,981.1% is down versus -142.2% a few years ago.
Bio Path Holdings stock price
Bio Path Holdings business model & stock analysis
Frequently asked questions about Bio Path Holdings
7 analysts currently rate the Bio Path Holdings stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Bio Path Holdings to generate revenue of 40.06 M USD and earnings per share of -0.22 USD.
Converted at the current exchange rate, the Bio Path Holdings share trades at 0.03 EUR (0.03 USD).
The Bio Path Holdings share (BPTH) is listed on 2 stock exchanges, including: NASDAQ (BPTH), Frankfurt (IBPB.F).
The expected revenue of Bio Path Holdings is 40.06 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Bio Path Holdings is -678,759.93 USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Bio Path Holdings is currently -0.13. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Bio Path Holdings stock.
The price-to-sales ratio (P/S) of Bio Path Holdings is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Bio Path Holdings stock.
The Eulerpool Quality Score for Bio Path Holdings is 2/10.
The ISIN of Bio Path Holdings is US09057N4097. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Bio Path Holdings is A2PB4K. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Bio Path Holdings is BPTH. The ticker symbol is used to trade Bio Path Holdings shares on the stock exchange.
Bio Path Holdings stock
Bio Path Holdings Peer Group
Bio Path Holdings Ticker
All fundamentals and in-depth analysis of Bio Path Holdings
Our stock analysis for Bio Path Holdings stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bio Path Holdings. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.